Product Image

BCQ

Vital Nutrients
4.5
★ ★ ★ ★ ★
(828 ratings)
Boswellia 600 mg
Bromelain 300 mg
Turmeric 600 mg
Product Image
Score73
Substantial curcuminoids, boswellia, bromelain, and quercetin give the formula meaningful breadth. High cost and incomplete potency or delivery details are the main weaknesses.
How scoring works
Quantity:120 Capsule(s) • (40 servings)
Goals:
Anti-Inflammatory Support
Joint Health
Digestive Health

Score 73

Substantial curcuminoids, boswellia, bromelain, and quercetin give the formula meaningful breadth. High cost and incomplete potency or delivery details are the main weaknesses.
How scoring works
$66.99($1.67 per serving)
Amazon
$ 66.99
Pure Formulas
$ 66.99
iHerb
$ 66.99
Report prices

Analysis

Three capsules provide 600 mg total curcuminoids, 600 mg boswellia gum extract, 300 mg bromelain, and 300 mg quercetin. Every active has a substantial disclosed amount, making the formula much more focused than basic whole-herb combinations.

The combination covers inflammatory signaling, joint comfort, antioxidant activity, and enzyme-related support. Boswellia lacks a quantified total-acid or AKBA percentage, while bromelain lacks activity units and timing guidance.

The bottle provides 40 servings and requires three capsules each time. The serving cost is very high makes it better suited to buyers who value ingredient breadth more than low-cost single-ingredient supplementation.

Who is it for
  • Adults seeking high-potency botanical capsules
  • Users who value clearly listed botanical weights
  • People who can screen herb-specific medication and tolerance concerns
Best for
  • Comparing botanical form and dose
  • Goal-aligned supplement selection
  • Users who prefer high-potency botanical capsules

Pros

  • High disclosed curcuminoid amount
  • Substantial boswellia and bromelain amounts
  • Adds 300 mg quercetin
  • Every active is individually quantified

Cons

  • Requires three capsules
  • Boswellia acid percentage is not stated
  • Bromelain activity units are missing
  • The serving cost is very high

Warnings

  • Curcuminoids and bromelain may increase bleeding tendency with anticoagulant or antiplatelet medicines
  • Bromelain can cause digestive upset and may trigger reactions in people sensitive to pineapple
  • Turmeric can aggravate symptoms in people with gallstones or bile-duct obstruction
  • Quercetin may alter handling of some medicines, so complex medication regimens deserve review

Nutrient quality

81 Highest impact

Substantial boswellia, curcuminoids, bromelain, and quercetin offer broad inflammation support. Missing active percentages, enzyme activity, and absorption technology temper the premium formula.

.

Ingredient transparency

84 Highest impact

Individual active weights are clearly disclosed. Some extract percentages, enzyme activity, or non-active label details remain incomplete.

.

Customer satisfaction

70 High impact

The supplied rating is favorable and the feedback base is adequate. No complaint-level evidence was supplied to assess recurring issues or purpose-specific experiences.

.

Value for money

53 Moderate impact

The serving cost is high relative to the certainty provided by the label. Substantial ingredients help, but disclosure gaps weaken category competitiveness.

.
Report analysis

Goals

Anti-Inflammatory Support
Impact
Highest effect
A Goal FitA- Strength of SupportA CoverageA+ Formula Quality
Boswellia · 600 mg

Boswellia, curcumin, bromelain, and quercetin combine direct enzyme modulation, antioxidant signaling, and proteolytic support. The disclosed amounts are substantial across the formula, creating broad and well-balanced anti-inflammatory coverage.

Active compounds are named for boswellia and turmeric, although percentages and absorption technology are not stated. Bromelain can increase bleeding tendency, so the 300 mg amount warrants caution with anticoagulant or antiplatelet medicines and before surgery.

Study evidence
Boswellia Supportive 19 studies
Bromelain Supportive 12 studies
Joint Health
Impact
Highest effect
A Goal FitB+ Strength of SupportA CoverageA+ Formula Quality
Boswellia · 600 mg

Boswellia, curcumin, bromelain, and quercetin create broad support for joint comfort and inflammatory balance. The major active amounts are substantial and individually disclosed.

Missing boswellic-acid percentages, curcuminoid standardization details, and bromelain enzyme activity limit potency assessment. Bromelain, curcumin, and quercetin may add to bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Boswellia Supportive 24 studies
Bromelain Mixed 5 studies
Digestive Health
Impact
Highest effect
B+ Goal FitB Strength of SupportB CoverageA Formula Quality
Bromelain · 300 mgBoswellia · 600 mg

Boswellia and curcumin target inflammatory signaling, while bromelain can support protein digestion and quercetin adds antioxidant activity. The combination offers useful digestive breadth, although clinical evidence varies by condition and extract quality.

The active weights are substantial, but boswellic-acid percentages, bromelain activity units, and curcumin absorption technology are not disclosed. Bromelain may increase bleeding risk with anticoagulant or antiplatelet medicines, so users of those drugs need individualized guidance.

Study evidence
Boswellia Supportive 9 studies
Bromelain Supportive 2 studies

Ingredients

IngredientAmount per serving
Boswellia serrata gum extract (Alpha Boswellic Acid, Beta Boswellic Acid)
600 mg
Bromelain
300 mg
Curcuma longa rhizome extract (Total Curcuminoids)
600 mg
Quercetin Dihydrate
300 mg
Gluten Free Adults 18–50 Dairy Free Sugar Free
Report overview
F Active Ingredient Quality & BioavailabilityC+ Dose, Safety & Label TransparencyF Value

The gum extract identifies alpha and beta boswellic acids, but it gives no active percentage or AKBA detail. A substantial dry-capsule amount may provide useful exposure, yet no absorption technology is disclosed. The high serving cost is difficult to justify for Boswellia alone, even though other botanicals and enzymes add broader formula value.

Bromelain · 300 mg OverallScore37
F Active Ingredient Quality & BioavailabilityD- Dose, Safety & Label TransparencyF Value

The bromelain amount is meaningful within the multi-ingredient formula. Enzyme activity and specific timing guidance are not disclosed, which limits confidence in potency and systemic use. The serving cost is high relative to the bromelain amount.

F Active Ingredient Quality & BioavailabilityC Dose, Safety & Label TransparencyD- Value

The active amount is meaningful for a curcumin-focused product. Source quality is limited by incomplete standardization details. The active dose is high, but the serving cost is expensive and no absorption enhancer is disclosed.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. An Evaluation of the Effects of Pineapple-Extract and Bromelain-Based Treatment after Mandibular Third Molar Surgery: A Randomized Three-Arm Clinical Study.
    Colletti A; Procchio C; Pisano M; Martelli A; Pellizzato M; Cravotto G · Nutrients · 2024
    Randomized trial42 participantsAnti-Inflammatory Support forBromelain
  2. A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee.
    Majeed M; Majeed S; Narayanan NK; Nagabhushanam K · Phytotherapy research : PTR · 2019
    Randomized trial48 participantsAnti-Inflammatory Support forBoswellia
  3. The role of enzyme supplementation in digestive disorders.
    Roxas M · Alternative medicine review : a journal of clinical therapeutic · 2009
    Narrative reviewDigestive Health forBromelain
  4. Effect of Oral Administration of Bromelain on Postoperative Discomfort After Third Molar Surgery.
    Ghensi P; Cucchi A; Creminelli L; Tomasi C; Zavan B; Maiorana C · The Journal of craniofacial surgery · 2018
    Randomized trial84 participantsAnti-Inflammatory Support forBromelain
  5. Double-blind trial of solid lipid Boswellia serrata particles (SLBSP) vs. standardized Boswellia serrata gum extract (BSE) for osteoarthritis of knee.
    Kulkarni PD; Damle ND; Singh S; Yadav KS; Ghante MR; Bhaskar VH; Hingorani L; Gota VS · Drug metabolism and personalized therapy · 2021
    Randomized trialAnti-Inflammatory Support forBoswellia
  6. Is bromelain an effective drug for the control of pain and inflammation associated with impacted third molar surgery? Systematic review and meta-analysis.
    de A C Almeida R; de Sousa Lima FCM; do E Vasconcelos BC · International journal of oral and maxillofacial surgery · 2019
    Meta-analysis252 participants5 studies pooledAnti-Inflammatory Support forBromelain
  7. Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohn's disease: good safety profile but lack of efficacy.
    Holtmeier W; Zeuzem S; Preiss J; Kruis W; Böhm S; Maaser C; Raedler A; Schmidt C; Schnitker J; Schwarz J; Zeitz M; Caspary W · Inflammatory bowel diseases · 2011
    Randomized trial108 participantsAnti-Inflammatory Support forBoswellia
  8. Clinical Benefits of Boswellia Serrata (BOSMAX®) in Early Knee Osteoarthritis: A Randomized, Placebo-Controlled, Double-Blind Study.
    Jayaram M; Kim J; Baek KS; Jung H; Kim J; M K P; T S C; H B S; Ramaiah V; S P · Journal of medicinal food · 2025
    Randomized trial150 participantsAnti-Inflammatory Support forBoswellia
  9. Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease.
    Karima S; Aghamollaii V; Mahmoodi Baram S; Balenci L; Lanctôt KL; Kiss A; Tafakhori A; Mahdavi M; Rajaei S; Shateri S; Yarhoseini A; Mokhtari F; Fotouhi A; Riazi A · Journal of Alzheimer's disease : JAD · 2023
    Randomized trial85 participantsAnti-Inflammatory Support forBoswellia
  10. A Standardized Boswellia serrata Extract Improves Knee Joint Function and Cartilage Morphology in Human Volunteers with Mild to Moderate Osteoarthritis in a Randomized Placebo-Controlled Study.
    Kumar B; Ghaytidak AB; Pandey AK; Somepalli RR; Sarda P; Raychaudhuri SP; Rokkam MP · Journal of the American Nutrition Association · 2025
    Randomized trial80 participantsAnti-Inflammatory Support Joint Health forBoswellia
  11. A standardized Boswellia serrata extract shows improvements in knee osteoarthritis within five days-a double-blind, randomized, three-arm, parallel-group, multi-center, placebo-controlled trial.
    Majeed A; Majeed S; Satish G; Manjunatha R; Rabbani SN; Patil NVP; Mundkur L · Frontiers in pharmacology · 2024
    Randomized trial105 participantsAnti-Inflammatory Support Joint Health forBoswellia
  12. Therapeutic efficacy of bromelain in impacted third molar surgery: a randomized controlled clinical study.
    Ordesi P; Pisoni L; Nannei P; Macchi M; Borloni R; Siervo S · Quintessence international (Berlin, Germany : 1985) · 2016
    Randomized trial80 participantsAnti-Inflammatory Support forBromelain
  13. Efficacy of proteolytic enzyme bromelain on health outcomes after third molar surgery. Systematic review and meta-analysis of randomized clinical trials.
    Mendes ML; do Nascimento-Júnior EM; Reinheimer DM; Martins-Filho PR · Medicina oral, patologia oral y cirugia bucal · 2019
    Meta-analysis6 studies pooledAnti-Inflammatory Support forBromelain
  14. Placebo-controlled randomized clinical trial on the immunomodulating activities of low- and high-dose bromelain after oral administration - new evidence on the antiinflammatory mode of action of bromelain.
    Müller S; März R; Schmolz M; Drewelow B; Eschmann K; Meiser P · Phytotherapy research : PTR · 2013
    Randomized trial12 participantsAnti-Inflammatory Support forBromelain
  15. Therapeutic uses of pineapple-extracted bromelain in surgical care - A review.
    Muhammad ZA; Ahmad T · JPMA. The Journal of the Pakistan Medical Association · 2019
    Narrative reviewAnti-Inflammatory Support forBromelain
  16. Positive Effects of a Lecithin-Based Delivery Form of Boswellia serrata Extract in Acute Diarrhea of Adult Subjects.
    Giacosa A; Riva A; Petrangolini G; Allegrini P; Fazia T; Bernardinelli L; Peroni G; Rondanelli M · Nutrients · 2022
    Randomized trial49 participantsDigestive Health forBoswellia
  17. Antioxidant Supplements and Gastrointestinal Diseases: A Critical Appraisal.
    Khan I; Samson SE; Grover AK · Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2018
    Narrative reviewDigestive Health forBoswellia
  18. Supplementation with a lecithin-based delivery form of Boswellia serrata extract (Casperome®) controls symptoms of mild irritable bowel syndrome.
    Belcaro G; Gizzi G; Pellegrini L; Corsi M; Dugall M; Cacchio M; Feragalli B; Togni S; Riva A; Eggenhoffner R; Giacomelli L · European review for medical and pharmacological sciences · 2018
    Non-randomized trial71 participantsDigestive Health forBoswellia
  19. Interventions for treating collagenous colitis.
    Kafil TS; Nguyen TM; Patton PH; MacDonald JK; Chande N; McDonald JW · The Cochrane database of systematic reviews · 2018
    Systematic review31 participants1 studies pooledDigestive Health forBoswellia
  20. Interventions for treating collagenous colitis.
    Chande N; McDonald JW; MacDonald JK · The Cochrane database of systematic reviews · 2007
    Systematic review31 participants1 studies pooledDigestive Health forBoswellia
  21. Effects of bromelain supplementation on disease activity and quality of life in patients with ulcerative colitis: a randomized, triple-blind, placebo-controlled study.
    Delgarm P; Mokhtare M; Ebrahimi Daryani N; Abolghasemi J; Rahideh ST · Scientific reports · 2025
    Randomized trial70 participantsDigestive Health forBromelain
  22. Oral herbal therapies for treating osteoarthritis.
    Cameron M; Chrubasik S · The Cochrane database of systematic reviews · 2015
    Meta-analysis5,980 participants49 studies pooledJoint Health forBoswellia
  23. Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study.
    Haroyan A; Mukuchyan V; Mkrtchyan N; Minasyan N; Gasparyan S; Sargsyan A; Narimanyan M; Hovhannisyan A · BMC complementary and alternative medicine · 2018
    Randomized trial201 participantsJoint Health forBoswellia
  24. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee.
    Sengupta K; Alluri KV; Satish AR; Mishra S; Golakoti T; Sarma KV; Dey D; Raychaudhuri SP · Arthritis research & therapy · 2009
    Randomized trial75 participantsJoint Health forBoswellia
  25. Bromelain as a Treatment for Osteoarthritis: a Review of Clinical Studies.
    Brien S; Lewith G; Walker A; Hicks SM; Middleton D · Evidence-based complementary and alternative medicine : eCAM · 2024
    Narrative reviewJoint Health forBromelain
  26. Improved WOMAC score following 16-week treatment with bromelain for knee osteoarthritis.
    Kasemsuk T; Saengpetch N; Sibmooh N; Unchern S · Clinical rheumatology · 2017
    Randomized trial40 participantsJoint Health forBromelain
  27. Oral enzyme combination therapy reduces systemic inflammation, urinary CTXII and pain in knee osteoarthritis: a proof-of-mechanism, randomised, crossover, double-blind, placebo-controlled trial.
    Henrotin Y; Pap T; Lieten S; Badot V; Dubuc JE; Urbin-Choffray D; von Eynatten M; Johansen OE; Rau S; Brabants K · RMD open · 2025
    Randomized trial45 participantsJoint Health forBromelain
  28. Efficacy, tolerability, and safety of an oral enzyme combination vs diclofenac in osteoarthritis of the knee: results of an individual patient-level pooled reanalysis of data from six randomized controlled trials
    Ueberall MA, Mueller-Schwefe GH, Wigand R, Essner U · Journal of Pain Research · 2016
    Meta-analysis697 participants6 studies pooledJoint Health forBromelain
  29. The safety and efficacy of an enzyme combination in managing knee osteoarthritis pain in adults: a randomized, double-blind, placebo-controlled trial
    Bolten WW, Glade MJ, Raum S, Ritz BW · Arthritis · 2015
    Randomized trial150 participantsJoint Health forBromelain